Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Stake Lifted by Capstone Financial Advisors Inc.

Capstone Financial Advisors Inc. increased its stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 18.7% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 136,026 shares of the pharmacy operator’s stock after buying an additional 21,386 shares during the quarter. Capstone Financial Advisors Inc.’s holdings in Walgreens Boots Alliance were worth $1,269,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in WBA. Northern Trust Corp raised its position in shares of Walgreens Boots Alliance by 18.8% during the 4th quarter. Northern Trust Corp now owns 8,896,742 shares of the pharmacy operator’s stock worth $83,007,000 after buying an additional 1,407,973 shares in the last quarter. Susquehanna Fundamental Investments LLC bought a new stake in shares of Walgreens Boots Alliance during the 4th quarter worth about $12,469,000. Coldstream Capital Management Inc. raised its position in shares of Walgreens Boots Alliance by 38.2% during the 4th quarter. Coldstream Capital Management Inc. now owns 44,459 shares of the pharmacy operator’s stock worth $415,000 after buying an additional 12,300 shares in the last quarter. Pingora Partners LLC raised its position in shares of Walgreens Boots Alliance by 69.9% during the 4th quarter. Pingora Partners LLC now owns 205,880 shares of the pharmacy operator’s stock worth $1,921,000 after buying an additional 84,672 shares in the last quarter. Finally, Syon Capital LLC raised its position in shares of Walgreens Boots Alliance by 96.0% during the 4th quarter. Syon Capital LLC now owns 24,753 shares of the pharmacy operator’s stock worth $231,000 after buying an additional 12,127 shares in the last quarter. 58.59% of the stock is currently owned by institutional investors.

Walgreens Boots Alliance Stock Performance

WBA stock opened at $11.01 on Monday. The company has a quick ratio of 0.30, a current ratio of 0.64 and a debt-to-equity ratio of 0.68. The company has a market capitalization of $9.52 billion, a price-to-earnings ratio of -1.08, a P/E/G ratio of 1.31 and a beta of 0.67. Walgreens Boots Alliance, Inc. has a 12 month low of $8.08 and a 12 month high of $18.83. The firm has a 50 day moving average of $10.95 and a two-hundred day moving average of $10.22.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its earnings results on Tuesday, April 8th. The pharmacy operator reported $0.63 EPS for the quarter, topping the consensus estimate of $0.53 by $0.10. The company had revenue of $38.59 billion during the quarter, compared to the consensus estimate of $37.90 billion. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. The company’s revenue for the quarter was up 4.1% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.20 earnings per share. As a group, equities analysts anticipate that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of analysts recently commented on WBA shares. Deutsche Bank Aktiengesellschaft downgraded shares of Walgreens Boots Alliance from a “hold” rating to a “sell” rating and dropped their target price for the stock from $11.00 to $9.00 in a report on Friday, February 28th. Bank of America boosted their target price on shares of Walgreens Boots Alliance from $7.50 to $8.50 and gave the stock an “underperform” rating in a report on Monday, January 13th. Evercore ISI lifted their target price on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock an “in-line” rating in a research report on Monday, January 13th. Wolfe Research raised shares of Walgreens Boots Alliance to a “hold” rating in a research report on Monday, February 24th. Finally, StockNews.com assumed coverage on shares of Walgreens Boots Alliance in a research report on Sunday. They issued a “hold” rating on the stock. Four research analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $10.59.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.